
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
The authors describe a methodology to evaluate various gelatin raw materials with respect to their stability and resistance to cross­linking.
about 25 years ago
Fast-Melting Tablets: Developments and Technologiesabout 25 years ago
Compendium of Pharmaceutical Excipients for Vaginal Formulations





